Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GALC ELISA Kit (AC3054)
Cat.#: ASET-1643
Specifications
Description Human GALC ELISA Kit allows for the in vitro quantitative determination of human GALC concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2197 Human HSD17B1 ELISA Kit (AC3608) Quantitative inquiry ASET-1169 Human CELSR2 ELISA Kit (AC2580) Quantitative inquiry ASET-2136 Human 5HT2A Receptor ELISA Kit (AC3547) Quantitative inquiry ASET-1791 Human CAPS1 ELISA Kit (AC3202) Quantitative inquiry ASET-1440 Mouse Axin 2 ELISA Kit (AC2851) Quantitative inquiry ASET-1122 Rat CX3CR1 ELISA Kit (AC2533) Quantitative inquiry ASET-1897 Mouse Estrogen Receptor beta ELISA Kit (AC3308) Quantitative inquiry ASET-2134 Human Myotrophin ELISA Kit (AC3545) Quantitative inquiry ASET-1370 Mouse C3 ELISA Kit (AC2781) Quantitative inquiry ASET-2372 Human GABA A Receptor alpha 1 ELISA Kit (AC3783) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket